322 related articles for article (PubMed ID: 9628245)
1. Final height and weight of long-term survivors of childhood malignancies.
Müller HL; Klinkhammer-Schalke M; Kühl J
Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245
[TBL] [Abstract][Full Text] [Related]
2. [A comparative study of the weight-height development of the long-term survivors of acute leukemia and solid tumors].
López Andreu JA; Albiach Mesado V; Ferrís i Tortajada J; Rodríguez Ineba A; Antonio Oriola P; Verdeguer Miralles A
An Esp Pediatr; 1999 Jun; 50(6):555-61. PubMed ID: 10410416
[TBL] [Abstract][Full Text] [Related]
3. Young adult survivors of childhood acute lymphoblastic leukemia: spontaneous GH secretion in relation to CNS radiation.
Jarfelt M; Bjarnason R; Lannering B
Pediatr Blood Cancer; 2004 Jun; 42(7):582-8. PubMed ID: 15127412
[TBL] [Abstract][Full Text] [Related]
4. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.
Dalton VK; Rue M; Silverman LB; Gelber RD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin M; Tarbell NJ; Sallan SE; Cohen LE
J Clin Oncol; 2003 Aug; 21(15):2953-60. PubMed ID: 12885815
[TBL] [Abstract][Full Text] [Related]
5. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation.
Bongers ME; Francken AB; Rouwé C; Kamps WA; Postma A
Pediatr Blood Cancer; 2005 Aug; 45(2):139-43. PubMed ID: 15714445
[TBL] [Abstract][Full Text] [Related]
6. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency.
Holm K; Nysom K; Rasmussen MH; Hertz H; Jacobsen N; Skakkebaek NE; Krabbe S; Müller J
Bone Marrow Transplant; 1996 Jul; 18(1):163-70. PubMed ID: 8832010
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors.
Hata M; Ogino I; Aida N; Saito K; Omura M; Kigasawa H; Toyoda Y; Tachibana K; Matsubara S; Inoue T
Int J Cancer; 2001; 96 Suppl():117-24. PubMed ID: 11992395
[TBL] [Abstract][Full Text] [Related]
8. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
Razzouk BI; Rose SR; Hongeng S; Wallace D; Smeltzer MP; Zacher M; Pui CH; Hudson MM
J Clin Oncol; 2007 Apr; 25(10):1183-9. PubMed ID: 17401007
[TBL] [Abstract][Full Text] [Related]
9. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
[TBL] [Abstract][Full Text] [Related]
10. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.
Spoudeas HA; Charmandari E; Brook CG
Med Pediatr Oncol; 2003 Apr; 40(4):224-9. PubMed ID: 12555249
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and factors affecting growth in long-term survivors of cancer.
Talvensaari KK; Knip M; Lanning P; Lanning M
Med Pediatr Oncol; 1996 Mar; 26(3):166-72. PubMed ID: 8544798
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia.
Vilela MI; Viana MB
Pediatr Blood Cancer; 2007 Jan; 48(1):86-92. PubMed ID: 16700045
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
15. [Results of an endocrinological follow-up of patients with childhood-or adolescent-onset malignancies].
Keller A; Bierbach U; Mieke J; Pfäffle R; Kratzsch J; Kiess W; Keller E; Körholz D
Klin Padiatr; 2007; 219(6):333-8. PubMed ID: 18050043
[TBL] [Abstract][Full Text] [Related]
16. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
17. The cohort of long-term survivors at the German childhood cancer registry.
Debling D; Spix C; Blettner M; Michaelis J; Kaatsch P
Klin Padiatr; 2008; 220(6):371-7. PubMed ID: 18949673
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between body mass index and leptin levels in children treated for acute lymphoblastic leukemia during and after maintenance therapy].
Muszyńska-Rosłan K; Krawczuk-Rybak M; Topczewska M; Sawicka-Zukowska M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):91-5. PubMed ID: 16813712
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in long-term survivors of childhood cancer.
Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiation.
Vandecruys E; Dhooge C; Craen M; Benoit Y; De Schepper J
J Pediatr; 2013 Jul; 163(1):268-73. PubMed ID: 23351599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]